neuronal precursors and that individual NEP cells can cytokines tested, optimum growth was seen when cells generate neuronal-restricted and glial-restricted precurwere cultured in medium supplemented with fibroblast sors. These data provide the first demonstration of a growth factor (FGF; 10 ng/ml) and neurotrophin-3 (NT-3; direct lineal relationship between multipotent and neu-10 ng/ml). In the presence of FGF/NT-3, most (Ͼ95%) ronal-restricted stem cells and suggest that neural dif-E-NCAM ϩ cells divided in culture to generate colonies ferentiation involves progressive restriction in developthat could contain several hundred cells. Figures 3B-3D mental fate.
show the development of one such clone. By day 5, most colonies (Ͼ95%) contained between 20-50 daughResults ter cells that continued to express E-NCAM immunoreactivity ( Figures 3D and 3E ). Daughter cells appeared E-NCAM Immunoreactive Cells Are Present in E13. 5 phase bright and had short processes ( Figures 3B-3D ).
Neural Tubes and Are Neuronal-Restricted
At this stage, most E-NCAM ϩ cells did not express ␤-III Stem Cells tubulin or neurofilament-L immunoreactivity (data not To determine if a dividing neuronal-restricted precursor shown). is present in vivo, we analyzed sections of E13. 5 spinal To promote differentiation of E-NCAM ϩ clones, the cords using a panel of early neuronal markers (data not FGF/NT-3 medium was replaced with medium lacking shown). Polysialated or embryonic NCAM (E-NCAM), FGF and containing retinoic acid (RA). In this differentiawhich is thought to play a critical role in early embryonic tion medium, E-NCAM ϩ cells stopped dividing, elabodevelopment (Chuong and Edelman, 1984; Linneman rated extensive processes, and started to express addiand Bock, 1989), was a likely marker since it has been tional neuronal markers (see table in Figure 3 ). Quadruple shown to be expressed in early neurogenesis (Chen labeling of clones with neuronal and glial markers and and Chiu, 1992; Blass-Kampmann et al., 1994) . E-NCAM bisbenzimide histochemistry to identify all cells showed immunoreactivity was first detected at E13.5 ( Figure 1) .
that all clones contained ␤-III tubulin ϩ cells (Figures 3F E-NCAM immunoreactive cells were seen in the margins and 3G) and that none of the E-NCAM ϩ clones differentiof the neural tube but not in the proliferating ventricular ated into oligodendrocytes or astrocytes (Figures 3F zone. Double labeling with an antibody to ␤-III tubulin and 3H). The neuronal character of E-NCAM ϩ cells was indicated that most E-NCAM immunoreactive cells cofurther confirmed by recording from randomly selected expressed this neuronal marker. A small proportion of E-NCAM ϩ cells. As can be seen in Figure 4 , all (four cells present more medially were E-NCAM ϩ but did not of four) recorded cells showed electrical activity and express ␤-III tubulin immunoreactivity, suggesting that generated action potentials in response to a depolariz-E-NCAM may be an early and specific marker of differening stimulus. tiation of neuronal precursors that is expressed prior to Although the absence of A2B5 immunoreactivity and ␤-III tubulin.
glial fibrillary acid (GFAP) immunoreactivity is a strong To further characterize E-NCAM immunoreactive indicator of the absence of glial differentiation, we tested cells, E13.5 spinal cords were dissociated and E-NCAMdifferentiated E-NCAM ϩ clones with additional markers expressing cells were double labeled with a panel of of the oligodendrocyte lineage. Randomly selected clones antibodies (Figures 2A-2F ). E-NCAM immunoreactive (5) were harvested and the cDNA analyzed for exprescells constituted 60% Ϯ 3% (average of three indepension of proteolipid protein (PLP, an oligodendrocyte dent experiments) of all cells present in dissociated culmarker) and Map-2 kinase (a neuronal marker). All (five ture 24 hr after plating. The majority of the remaining of five) clones tested expressed Map-2 kinase but not cells were A2B5 ϩ (Eisenbarth et al., 1979) . We have pre-PLP ( Figure 4A ). In parallel, other E-NCAM ϩ clones (17) viously shown that at this stage, A2B5 immunoreactive were processed for immunohistochemistry to show that cells are glial precursor cells (Rao and Mayer-Proschel, neither O4 nor Gal-C immunoreactivity was detectable 1997). Consistent with our previous results, ␤-III tubulin in differentiated E-NCAM ϩ clones ( Figure 4B ). To further or E-NCAM immunoreactive (ϩ) cells did not coexpress confirm that most E-NCAM ϩ clones had differentiated A2B5 (Figures 2A and 10 ; data not shown). The vast into neurons, some clones were labeled with Map-2 majority of cultured E-NCAM immunoreactive cells (85%Ϯ kinase and neurofilament antibodies (Figures 4D and 8%) coexpressed ␤-III tubulin immunoreactivity (Figures 4E, respectively) . Virtually all E-NCAM ϩ cells expressed 2C and 2D) and other neuronal markers (see Figure 2G Map-2 kinase and neurofilament-M, demonstrating that and table in Figure 2 ) as well as nestin immunoreactivity E-NCAM ϩ cells are restricted in their differentiation po-( Figures 2E and 2F ) but did not express markers charactential. teristic of glial precursors (see table in Figure 2 ), consisThe inability to detect oligodendrocyte and astrocyte tent with the in vivo segregation of E-NCAM and glial differentiation was unlikely to be due to the death of precursor immunoreactivity (Warf et al., 1991; Noll and oligodendrocytes and astrocytes that might have differMiller, 1993; Pringle and Richardson, 1993; entiated from E-NCAM ϩ precursors, as A2B5 ϩ glial preal., 1996) . Approximately 20% of the E-NCAM ϩ cells cursor cells purified and grown in parallel in the presence divided in a 24 hr period ( Figure 2B ). Most of the dividing of FGF and NT-3 continued to express A2B5 without E-NCAM ϩ cells did not coexpress ␤-III tubulin (data not apparent cell death ( Figures 5C and 5D ) and generated shown), indicating that this population of cells could healthy oligodendrocytes and astrocytes after 10 days represent a dividing neuroblast. in culture (data not shown; Fok-Seang and Miller, 1994 ; To determine the differentiation potential of E-NCAM ϩ Rao and Mayer-Proschel, 1997) . In addition, A2B5 ϩ cells cells, the E-NCAM ϩ population was purified by immunonever generated neurons in the presence of FGF/NT3 panning ( Figure 3A ) and plated at clonal density in gridded dishes (see Experimental Procedures). Of all the and showed no expression of E-NCAM at any time tested (Figures 5A and 5B) . Thus E-NCAM immunoreacpromotes astrocyte differentiation of both spinal cord NEP cells and A2B5 immunoreactive glial precursor cells tive cells, unlike A2B5 immunoreactive glial-restricted precursors, could not differentiate into oligodendro- (Rao and Mayer-Proschel, 1997; Kalyani et al., 1997) . All (24 of 24) E-NCAM ϩ clones that were grown in neuronalcytes or astrocytes and appeared limited to neuronal differentiation when compared to multipotential E10. 5 promoting medium contained only ␤-III tubulin ϩ cells after 8 days, as described previously, while the clones neuroepithelial cells.
While we have clearly shown that in our system, grown in serum-containing medium did not generate astrocytes or proliferate. From a total of 97 E-NCAM ϩ E-NCAM identifies neuronal-restricted precursor cells, it has been reported that certain glial precursors at later clones grown in glial-promoting conditions, 90 clones (92%) consisted of a single dead cell after 24 hr, while stages in development can also express E-NCAM immunoreactivity (Blass-Kampmann et al., 1994) . We and oththe remaining 7 clones (8%) contained one or two dead cells after 48 hr. Thus, E-NCAM immunoreactive cells, ers (e.g., Chen and Chiu, 1992) is seen in Figure 6 , no E-NCAM ϩ clone generated GFAP We have previously shown that individual NEP cells derived from embryonic day 10.5 spinal cord are an E-NCAM 7 shows that all clones examined generated numerous daughter clones, which subsequently generated tertiary immunonegative, multipotent, self-renewing population of cells that can generate neurons, astrocytes, and oligoclones. Small clones and very large clones showed similar self renewal potential. When tertiary clones were dendrocytes (Kalyani et al., 1997) . To determine if neuronal differentiation from NEP precursors involved the switched to a medium containing RA and lacking FGF, the majority of cells in a clone differentiated into postmi Figure 8A ) but coexpressed ␤-III tubulin (20%-30%) and nestin (70%-80%) immunoreactivity (data not shown and Figure 8B , respectively). Ninety percent of panned E-NCAM ϩ cells incorporated BrdU in culture ( Figure 7C ) and generated neurons after addition of RA or NT-3 and thus appeared similar to the E13.5 E-NCAM immunoreactive cells. Thus E-NCAM Ϫ NEP cells differentiate into E-NCAM ϩ cells under appropriate differentiation signals.
To determine whether single E-NCAM ϩ cells that were generated from E-NCAM Ϫ NEP cells were also restricted to neuronal differentiation, NEP-derived E-NCAM ϩ cells were studied in clonal culture. NEP cells (E-NCAM Ϫ ) were induced to differentiate by replating on laminin lacking chick embryo extract as previously described (Kalyani et al., 1997) . Forty-eight hours after cells were allowed to differentiate, 10%-30% of the cells had begun to express E-NCAM immunoreactivity. NEP-derived E-NCAM ϩ cells were selected by immunopanning, individual E-NCAM ϩ cells were plated in medium containing FGF/NT3, and clones were analyzed after 10 days. All clones contained E-NCAM ϩ /␤-III tubulin ϩ cells ( Figure  9 ) but not GFAP or A2B5 immunoreactive cells (data not shown). In addition, individual E-NCAM ϩ cells failed to differentiate into oligodendrocytes or astrocytes under culture conditions that promoted astrocytic and oligodendroglial differentiation from the parent NEP cell population (data not shown). E-NCAM ϩ cells could be maintained as dividing precursor cells in defined medium in the presence of high concentrations of FGF (10 ng/ml) and NT-3 (10 ng/ml). E-NCAM ϩ cells maintained for up to 3 months could readily differentiate into ␤-III tubulin ϩ mature neurons that expressed a variety of neurotransmitter phenotypes when exposed to RA and grown on laminin. Thus, NEP-derived E-NCAM ϩ cells are similar to E13.5 neuronal precursors in their differentiation potential, in their antigenic profile, and in the conditions optimal for extended growth as a dividing precursor cell population.
E-NCAM Immunoreactive Cells Are Generated from a Common Neuroglial NEP Progenitor Cell Differentiation of the E-NCAM
ϩ population from an apparently homogeneous nestin ϩ /E-NCAM Ϫ NEP cell population suggests a progressive restriction in develop- antibody. Greater than 95% of the cells were E-NCAM ϩ (see Results) at that time. Purified and stained cells were plated on gridded clonal dishes and individual E-NCAM ϩ cells were identified and followed over time. Panels (B) (day 1), (C) (day 3), and (D) (day 5) are representative and withdrawal of FGF and quadruple labeled with bisbenzimide pictures of an E-NCAM immunoreactive clone at different stages of (blue, [G] and [H] ) and antibodies to A2B5 (green, [H]), GFAP (green, development.
[H]), and ␤-III tubulin (red, [G] clones for their ability to generate E-NCAM immunoreacTo test if most neurons were generated via an E-NCAM ϩ intermediate neuroblast, we utilized completive cells and A2B5 immunoreactive cells. A2B5 and E-NCAM were chosen since we and others have prement-mediated cell lysis to selectively kill E-NCAM ϩ cells. Twenty-four hours after replating NEP cells in difviously shown that A2B5 immunoreactivity is unique to oligodendrocyte-astrocyte precursors at this stage of ferentiating conditions, E-NCAM immunoreactive cells were killed using an IgM antibody to E-NCAM and guinea development (Warf et al., 1991; Miller, 1992, 1994; Pringle et al., 1996; Rao and Mayer-Prospig complement (see Experimental Procedures) . In sister plates, glial precursors were killed using an anti-A2B5 chel, 1997; Kalyani et al., 1997) . NEP cells were plated in clonal culture as previously described (Kalyani et al.,
IgM antibody and complement. At this stage in development, most E-NCAM ϩ cells do not express ␤-III tubulin 1997), and their development was followed for 7 days. Of 112 NEP clones that were followed in culture, 83%
(unpublished data). Treated plates were allowed to differentiate for an additional 3 days, and the developof the clones contained both A2B5 and E-NCAM immunoreactive cells (Figure 10 ). Five percent of the clones ment of neurons was monitored. E-NCAM-mediated lysis significantly reduced the number of ␤-III tubulin consisted of A2B5 immunoreactive but not E-NCAM immunoreactive cells, and 12% of the clones showed no immunoreactive cells that developed when compared to cultures treated with A2B5 (219 Ϯ 35 versus 879 Ϯ 63, convincing staining for either A2B5 or E-NCAM immunoreactivity. In all clones tested, E-NCAM and A2B5 were respectively; mean of two independent experiments), suggesting that neuronal differentiation from NEP cells expressed in nonoverlapping populations. The ability of the E-NCAM ϩ and A2B5 ϩ cells to generate neurons and/ in vitro requires a transition through an E-NCAM immunoreactive state. or glial cells was tested by selecting cells from individual clones and monitoring their development (data not shown; see also Rao and Mayer-Proschel, 1997 1996; McKay, 1997; Stemple and Mahanthappa, 1997;  cell culture studies have suggested a common neurooligo precursor and a neuro-astrocyte precursor (Sanes Morrison et al., 1997) . Our results provide direct evidence to support a model describing initially multipotent et al., 1986; Price et al., 1987 Price et al., , 1992 Sanes, 1989; Williams et al., 1991; Lois and Alvarez-Buylla, 1993; Williams, 1995 (Ray and Gage, 1994; Temple and Davis, 1994;  are restricted in their developmental potential. E-NCAM cells readily differentiate into neurons but fail to difreviewed by Morrison et al., 1997) , this represents a direct demonstration of a transition from a multipotent ferentiate into oligodendrocytes or astrocytes under all culture conditions tested. We have, therefore, called to a more restricted neuronal stem cell in the nervous system. E-NCAM immunoreactive cells neuronal-restricted precursors or NRPs. We have seen occasional ␣-GFAP ϩ Additional results from our laboratories suggest that A2B5 immunoreactive glial precursors also arise from cells present in the largest clones (Ͻ1% of the total clones analyzed) after repeated subcloning over 3 NEP cells (Rao and Mayer-Proschel, 1997 
E-NCAM Immunoreactive Cells Do Not Differentiate into Astrocytes E-NCAM
ϩ and E-NCAM Ϫ cells from E13.5 rat spinal cords were separated by immunopanning (see Experimental Procedures) and plated in clonal culture in medium containing FGF and CNTF. Cells were allowed to grow in this glial condition for 10 days. Cultures were then fixed and double labeled with antibodies to E-NCAM (red) and GFAP (green). The table in (A) summarizes the results from one such clonal experiment, while (B) and (C) show one representative clone of E-NCAM ϩ and E-NCAM Ϫ cells. Note that no E-NCAM immunoreactive clone contained GFAP immunoreactive cells. In contrast, E-NCAM Ϫ cells readily differentiated into GFAP ϩ astrocytes under these conditions. Note also that no GFAP ϩ cell expressed E-NCAM immunoreactivity.
astrocytes may be a property acquired through precursor maturation (Smith-Thomas et al., 1990; Pixley, 1992; Kilpatrick et al., 1993; Mehler et al., 1995; Gross et al., 1996) in vitro. Proving or disproving these alternatives is difficult, given our limited knowledge of the molecular events underlying neuroglial interactions. In any case, the E-NCAM ϩ cells are clearly distinct from NEP cells and A2B5 glial precursor cells in their relative inability to differentiate into astrocytes.
We have clearly demonstrated that multipotent stem cells exist and can generate restricted self-renewing precursors and that such restricted precursors are also generated during normal development. Further, our complement killing experiments with E10.5 NEP cells into single cell clones of neurons, suggesting that a Rigorous demonstration of the multipotentiality of stem cells that differentiof SVZ cells with E-NCAM ϩ neuroblasts will reveal the relationship between these cells, the SVZ, and other ated into neurons without cell division, however, was not possible, since unambiguous markers for multipotential spinal cord neuronal precursors. The cytokine dependence of the E-NCAM neuroblast stem cells were unavailable. It is also possible that the mode of differentiation of stem cells may depend on precursor, its restricted differentiation potential, and its self renewal capabilities are similar to those of the spinal environmental cues (reviewed by Morrison et al., 1997) . A multipotential stem cell may not always differentiate cord neuroblast precursor isolated by Ray and Gage (1994) . In their mass culture experiments, the authors into a neuron via an intermediate precursor cell. It may, under different culture conditions, mature into a neuron were unable to prove that the neuroblast cell does not generate astrocytes. We have obtained results that conwithout undergoing any rounds of division. While we cannot completely exclude the existence of alternate firm and extend their observations. By identifying a cell surface epitope (E-NCAM) that can be used to isolate models of differentiation, our data provide compelling evidence that intermediate precursors are lineally rethe precursors and using clonal analysis to demonstrate a restriction to neuronal differentiation, we have shown lated to and arise from multipotent precursors, and they also suggest that differentiation of at least some stem that individual E-NCAM immunoreactive cells are neuronal-restricted precursor cells. More importantly, we cells in the CNS involves a progressive restriction in developmental potential.
demonstrate that the neuroblast precursor differentiates from an earlier, less restricted precursor. We have also demonstrated that E-NCAM ϩ cells present in vivo at E13.5 are neuronal-restricted precursors.
Our immunopanning and double labeling data demonstrate that E-NCAM can be used to identify a specific Immunocytochemical labeling with E-NCAM suggests that E-NCAM ϩ cells are not present in the ventricular neuronal sublineage that is generated from multipotential NEP cells. Like markers for intermediate precursors zone but can be detected in cells migrating away from the ventricular zone, suggesting that these cells may be in the hematopoietic system and neural crest, however, E-NCAM (and the A2B5 glial precursor marker as well) identical to the SVZ precursor cells that proliferate and migrate to the olfactory bulb (reviewed by Temple and are not unique to intermediate precursors. E-NCAM has been shown to label some astrocytes (Blass-Kampmann Qian, 1996) . The ability to self renew and divide to form large clones of precursor cells further supports this hyet al., 1994). Similarly, A2B5 has been shown to recognize neurons in some species (Eisenbarth et al., 1979; pothesis. However, no SVZ equivalent has been identified Mixed Clones that Contain Other Restricted Precursors NEP cells derived from E10.5 embryos were expanded in the pres-NEP cells derived from E10.5 embryos were expanded in the presence of FGF and CEE for 5 days and differentiated by replating on ence of FGF and CEE for 5 days, harvested by trypsinization and laminin in the absence of CEE. Immunopanned E-NCAM ϩ cells were replated at clonal density in gridded clonal dishes. After 7 days in then plated on gridded clonal dishes coated with fibronectin/laminin, culture, individual clones were double labeled with antibodies and single cells were followed in culture. After 5 days, clones were against E-NCAM and A2B5 as described in the Experimental Proceswitched to RA and FGF was withdrawn. Clones were allowed to dures. The upper panel shows one such NEP clone that contained grow for an additional 3 days, fixed with paraformaldehyde, and both E-NCAM (red) and A2B5 ( precursor cell (NRP), present at E13.5, that has lost the ability to generate astrocytes or oligodendrocytes but retains the ability to generate multiple neuronal pheno- Girdlestone and Weston, 1985; Goldman, 1990; Satoh and Kim, 1995) and is transiently expressed by astrotypes. NRPs are lineally related to and arise from multipotent NEP stem cells. Both neuronal-restricted and cytes in some culture conditions . Nevertheless, under the specific culglial-restricted precursors can arise from a common multipotent stem cell, suggesting a sibling relationship ture conditions defined above, these markers may be used to select intermediate precursors and therefore between these two classes of precursors. Our results provide a culture model for in vivo differentiation that is represent the first cell surface epitopes that are coexpressed in concordance with a restriction in developamenable to perturbation, allowing the process of neural lineage restriction and differentiation to be charactermental potential. Analysis in other species will reveal whether these markers will serve equally well in identiized in detail. Further, our results show that E-NCAM can be used for selectively sorting and amplifying NRPs fying intermediate precursors in other species. allowed to settle for 4 hr; single cells were identified, and their through serial passages for gene expression studies and development was followed in culture. NEP cells were grown in NEP therapeutic use. medium as described above, and neuroblasts were grown in NEP medium with the addition of NT-3 (20 ng/ml) and the withdrawal of Experimental Procedures CEE. In most experiments, clonal cultures were terminated after 12 days. In these assays, ‫%02-%01ف‬ of single cells died within 24 hr.
Substrate Preparation
Clonal plates were usually triple labeled with the cell surface antigen Laminin, used at a concentration of 20 mg/ml (Biomedical Technoloand the appropriate secondary antibodies. gies), was dissolved in distilled water and applied to tissue culture plates (Falcon). For the fibronectin solution, fibronectin (Sigma) was
Immunopanning of E-NCAM ؉ Cells resuspended to a stock concentration of 10 mg/ml, stored at Ϫ80ЊC NEP cells were cultured in ϪCEE conditions for 6 days, and the and diluted to a concentration of 250 g/ml in Dulbecco's phos-E-NCAM ϩ cell population was purified using a specific antibodyphate-beffered saline (DPBS; Gibco). The fibronectin solution was capture assay (Wysocki and Sato, 1978) with modification. In brief, applied to tissue culture dishes and immediately withdrawn. Subsecells were trypsinized and the suspension was plated on an A2B5 quently, the laminin solution was applied, and the plates were incuantibody-coated dish (Eisenbarth et al., 1979) to allow binding of all bated for 5 hr. Excess laminin was withdrawn, and the plates were A2B5 ϩ cells to the plate. The supernatant was removed, and the allowed to air dry. Plates were rinsed with water and then allowed plate was washed with DMEM supplemented with additives deto dry again.
scribed by Bottenstein and Sato (1979; DMEM-BS). The supernatant was then plated on an E-NCAM antibody-coated dish to allow bindNeuroepithelial Cell Cultures ing of the E-NCAM immunoreactive cells. The bound cells were Sprague-Dawley rat embryos were removed at embryonic day 10.5 scraped off and plated on fibronectin/laminin-coated glass covor 13.5 and placed in a petri dish containing Hanks' balanced salt erslips in 300 l of DMEM-BS Ϯ growth factors at 5000 cells/well. solution (HBSS; Gibco). The trunk segments of the embryos (last The A2B5 and E-NCAM antibody for coating the plates was used ten somites) were dissected using tungsten needles, rinsed, and at a concentration of 5 g/ml. Cells were allowed to bind to the then transferred to fresh HBSS. Trunk segments were incubated at plate for 20-30 min in a 37ЊC incubator. Growth factors were added 4ЊC in 1% trypsin solution (Gibco) for 10-12 min. The trypsin solution every other day at a concentration of 10 ng/ml. Recombinant bFGF was replaced with fresh HBSS containing 10% fetal bovine serum and NT3 were purchased from PeproTech, and retinoic acid (RA) (FBS). The segments were gently triturated with a Pasteur pipette was obtained from Sigma. to release neural tubes from surrounding somites and connective tissue. Isolated neural tubes were transferred to a 0.05% trypsin/ Gene Detection by RT-PCR EDTA solution (Gibco) and incubated for 10 min. Cells were dissoci-RNA Isolation ated by trituration and plated in 35 mm dishes (Nunc) at high density.
Total RNA was isolated from cells or whole tissues by a modification Cells were maintained at 37ЊC in 5% CO 2/95% O2. Cells were reof the guanidine isothiocyanate-phenol-chloroform extraction method plated at low density after 3 days. Cells from several dishes were (TRIZOL, Gibco-BRL, Burlington, Ontario, Canada). then harvested by trypsinization (0.05% trypsin/EDTA solution for cDNA Synthesis 2 min), pelleted, resuspended in a small volume, and replated at a cDNA was synthesized using 1-5 g of total RNA in a 20 l reaction. density of 5000 cells/35 mm dish. The basal medium used in all Superscript II (Gibco-BRL), a modified Maloney murine leukemia experiments was a chemically defined medium modified from that virus RT, and Oligo (dT) 12-18 primers were used according to the described by Stemple et al. (1988) . The medium consisted of DMEMmanufacturer's (Gibco-BRL) protocols. F12 (Gibco) supplemented with additives described by Bottenstein PCR and Sato (1979), bFGF (20 ng/ml), and chick embryo extract (CEE;
Aliquots of cDNA, equivalent to 1/20 of the above reaction, were 10%), prepared as described previously (Stemple and Anderson, used in a 50 l reaction volume. PCR amplification of different genes 1992).
was performed using Elongase polymerase (Gibco-BRL). Primer sequences and cycling temperatures were optimized using whole Generation of Neurons, Oligodendrocytes, and Astrocytes brain cDNA, and initial amplification products were sequenced to Neuroepithelial cells cultured in nondifferentiating conditions for 5 confirm the specificity of the amplification product. Unless otherdays were harvested by trypsinization and replated onto dishes wise specified, PCR reactions were run for 35 cycles (94ЊC for 1 sequentially coated with fibronectin/laminin (0.25 mg/ml) in neuromin, 56ЊC for 1 min, and 68ЊC for 1 min). A 10 min incubation at epithelial culture medium. For neuronal and oligodendrocyte differ-72ЊC was added at the end to ensure complete extension. The PCR entiation, the medium consisted of neuroepithelial culture medium products were purified using the Advantage PCR-Pure Kit (Clontech, described above with the omission of 10% CEE (ϪCEE condition).
Palo Alto, CA) and used for sequence analysis, restriction enzyme For astrocyte differentiation, the ϪCEE medium was supplemented digest reactions, subcloning, and slot blot experiments as described with 10% fetal calf serum. Differentiation was assayed 5 or 9 days in the results. after replating (as detailed in the Results).
For differentiation of neuroblast cells, FGF was withdrawn, and retinoic acid (RA; Sigma) was added. Differentiation was assessed Immunocytochemistry Staining procedures were performed as described previously (Rao 48 hr after changing the medium.
and Mayer-Proschel, 1997) . Staining for the cell surface markers E-NCAM, A2B5, and Gal-C (cell lines obtained from ATCC) was Cultures of Neuronal-Restricted Precursor Cells Sprague-Dawley rat embryos were removed at E13.5 and placed in carried out in cultures of living cells. To stain cells with antibodies against the internal antigen GFAP (Sigma), which specifically recoga petri dish containing Hanks' balanced salt solution (HBSS; Gibco). The trunk segments of the embryos were dissected using tungsten nizes astrocytes (Bignami et al., 1972) ; ␤-III tubulin (GIBCO), which stain neurons; nestin (DSHB), a marker for undifferentiated stem needles, rinsed, and then transferred to fresh HBSS. Spinal cords were mechanically dissected from the surrounding connective tiscells (Lendahl et al., 1990); or 5-bromodeoxyuridine (BrdU; Sigma) , to determine the number of dividing cells, cultures were fixed with sue using sharpened No 5 forceps. Isolated spinal cords were incubated in 0.05% trypsin solution for twenty min. The trypsin solution ice-cold methanol. All secondary monoclonal antibodies were purchased from Southern Biotechnology. was replaced with fresh HBSS containing 10% fetal bovine serum (FBS). The segments were gently triturated with a Pasteur pipette Double and triple labeling experiments were performed by simultaneously incubating cells in appropriate combinations of primary to dissociate cells. Cells dissociated by trituration were plated in 35 mm dishes (Nunc) at high density.
antibodies, followed by incubation with non-crossreactive secondary antibodies. In triple label experiments, cultures were incubated with the primary antibody in blocking buffer for 1 hr, rinsed with Clonal Cultures of Neuroepithelial Cells and Neuroblasts Either panned cells or immunostained cells were trypsinized and buffer (PBS), and incubated with a species-specific secondary antibody in blocking buffer for 1 hr. Cultures were rinsed three times plated in gridded clonal culture dishes (Greiner Labortechnik) coated with fibronectin/laminin at a dilution of 100 cells/dish. Cells were with PBS and examined under a fluorescent microscope.
